CA2076722A1 - Pharmaceutical agents - Google Patents

Pharmaceutical agents

Info

Publication number
CA2076722A1
CA2076722A1 CA002076722A CA2076722A CA2076722A1 CA 2076722 A1 CA2076722 A1 CA 2076722A1 CA 002076722 A CA002076722 A CA 002076722A CA 2076722 A CA2076722 A CA 2076722A CA 2076722 A1 CA2076722 A1 CA 2076722A1
Authority
CA
Canada
Prior art keywords
methyl
methanol
methoxy
benzamide
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002076722A
Other languages
English (en)
French (fr)
Inventor
Murray W. Cuthbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2076722A1 publication Critical patent/CA2076722A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002076722A 1991-09-05 1992-08-24 Pharmaceutical agents Abandoned CA2076722A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9119001.7 1991-09-05
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (1)

Publication Number Publication Date
CA2076722A1 true CA2076722A1 (en) 1993-03-06

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002076722A Abandoned CA2076722A1 (en) 1991-09-05 1992-08-24 Pharmaceutical agents

Country Status (21)

Country Link
US (2) US5352694A (enExample)
EP (1) EP0531078B1 (enExample)
JP (1) JP2914414B2 (enExample)
KR (1) KR100254710B1 (enExample)
AT (1) ATE138910T1 (enExample)
AU (1) AU646587B2 (enExample)
CA (1) CA2076722A1 (enExample)
CZ (1) CZ281999B6 (enExample)
DE (1) DE69211258T2 (enExample)
DK (1) DK0531078T3 (enExample)
FI (1) FI102372B (enExample)
GB (2) GB9119001D0 (enExample)
HK (1) HK18297A (enExample)
HU (2) HU213410B (enExample)
IL (1) IL102856A (enExample)
NO (1) NO178370C (enExample)
NZ (1) NZ244016A (enExample)
RU (1) RU2095348C1 (enExample)
SK (1) SK267092A3 (enExample)
TW (1) TW302359B (enExample)
ZA (1) ZA926374B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
JP3983272B2 (ja) 2004-07-14 2007-09-26 有限会社 炎症研究所 腫瘍転移の抑制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
ATE138910T1 (de) 1996-06-15
US5466826A (en) 1995-11-14
HU9202660D0 (en) 1992-10-28
IL102856A (en) 1996-12-05
FI102372B1 (fi) 1998-11-30
SK279657B6 (sk) 1999-02-11
EP0531078B1 (en) 1996-06-05
HK18297A (en) 1997-02-13
FI923869A0 (fi) 1992-08-28
SK267092A3 (en) 1999-02-11
HU210879A9 (en) 1995-09-28
AU646587B2 (en) 1994-02-24
JPH05194385A (ja) 1993-08-03
DE69211258T2 (de) 1996-10-02
GB9119001D0 (en) 1991-10-23
KR930005976A (ko) 1993-04-20
KR100254710B1 (ko) 2000-05-01
RU2095348C1 (ru) 1997-11-10
IL102856A0 (en) 1993-01-31
ZA926374B (en) 1993-03-05
GB9216774D0 (en) 1992-09-23
FI923869L (fi) 1993-03-06
CZ281999B6 (cs) 1997-04-16
CZ267092A3 (en) 1993-03-17
HUT69696A (en) 1995-09-28
US5352694A (en) 1994-10-04
NO923467L (no) 1993-03-08
DK0531078T3 (da) 1996-10-14
NO178370B (no) 1995-12-04
NZ244016A (en) 1995-01-27
AU2101292A (en) 1993-03-11
JP2914414B2 (ja) 1999-06-28
EP0531078A1 (en) 1993-03-10
NO923467D0 (no) 1992-09-04
TW302359B (enExample) 1997-04-11
HU213410B (en) 1997-06-30
FI102372B (fi) 1998-11-30
NO178370C (no) 1996-03-13
DE69211258D1 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
BG61323B2 (bg) Производни на пиперидина,тяхното получаване и използването им като лекарства
JP2007503423A (ja) フェキソフェナジンの結晶多形、及びそれらを製造する方法
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
JP4184666B2 (ja) カベルゴリンの結晶性形態ｉを調製するための方法
HU217118B (hu) Eljárás kristályos 4-(di-n-propil)-amino-6-(amino-karbonil)-1,3,4,5-tetrahidro-benz[c,d]indol-hippurát és a vegyületet tartalmazó gyógyászati készítmények előállítására
US20060142299A1 (en) Crystalline aripiprazole solvates
US20060106227A1 (en) 3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
EP1499581A1 (en) Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
CA2031897C (en) Carbamoyl derivatives
TWI499584B (zh) ４－｛３－［順－六氫環戊［ｃ］吡咯－２（１ｈ）－基］丙氧基｝苯甲醯胺鹽酸鹽之晶形及其合成方法及含彼之醫藥組合物
CA2076722A1 (en) Pharmaceutical agents
JPS61501854A (ja) 新規なド−パミン・アゴニスト
MXPA03011728A (es) Formas cristalinas novedosas del acido 4-[4-[4- (hidroxidifenilmetil) -1-piperidinil] -1-hidroxibutil] -alfa, alfa -dimetilbencen acetico y su clorohidrato.
TW201427949A (zh) 塔適那偉（ａｔａｚａｎａｖｉｒ）硫酸氫鹽之製法及其新穎的形式
WO2006108151A1 (en) Crystalline forms of pregabalin
JPS62145080A (ja) Ｎ−（ピロ−ル−１−イル）ピリジンアミン類およびそれらの製造方法
CA2056068C (en) Process
US5006533A (en) Certain 3-bromo-2,6-dimethoxybenzamides and pharmaceutical use thereof
JP3001975B2 (ja) 結晶性チアガビン塩酸塩−水和物、その製造方法および用途
WO2003105836A1 (en) 3-'2-(Dimethylamino) ethyl!-N-methyl-1H-indole-5-methanesulfonamide and the Succinate Thereof
JP2005537218A (ja) フェキソフェナジン塩基の多形体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued